Floatz logo

IMMUNOGLOBULIN G1, (HUMANIZED MONOCLONAL 3E10 .GAMMA.1-CHAIN FAB FRAGMENT) FUSION PROTEIN WITH 67-952-LYSOSOMAL .ALPHA.-GLUCOSIDASE (HUMAN RECOMBINANT), DISULFIDE WITH HUMANIZED MONOCLONAL 3E10 .KAPPA.-CHAIN

Pompe Disease

Valerion Therapeutics, LLCprotein_peptidePhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Pompe Disease cohort.

Asset / SponsorPhaseRating
Avalglucosidase Alfa
Genzyme, a Sanofi Company
Phase 4A
Alglucosidase Alfa
Erasmus Medical Center
Phase 4A
Avalglucosidase Alfa
Genzyme, a Sanofi Company
Phase 4A
Albuterol
National Taiwan University Hospital
Phase 4BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University of Florida
Phase 4BB

View all 28 →

Same molecule, other indications

IMMUNOGLOBULIN G1, (HUMANIZED MONOCLONAL 3E10 .GAMMA.1-CHAIN FAB FRAGMENT) FUSION PROTEIN WITH 67-952-LYSOSOMAL .ALPHA.-GLUCOSIDASE (HUMAN RECOMBINANT), DISULFIDE WITH HUMANIZED MONOCLONAL 3E10 .KAPPA.-CHAIN is also rated in:

Lafora diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →